Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al

Autor:	Levent M. Senturk, Gesthimani Mintziori, Irene Lambrinoudaki, Faustino R. Pérez-López, Panagiotis Anagnostis, John C. Stevenson, Tommaso Simoncini, Petra Stute, Margaret Rees, Herman Depypere, Alfred O. Mueck, Stavroula A Paschou, Iuliana Ceausu, Florence Tremollieres, Dimitrios G. Goulis
Jazyk:	angličtina
Rok vydání:	2017
Předmět:	Genetics and Molecular Biology (all) Pediatrics medicine.medical_specialty Biochemistry Genetics and Molecular Biology (all) Obstetrics and Gynecology business.industry Osteoporosis MEDLINE 030209 endocrinology & metabolism medicine.disease Biochemistry General Biochemistry Genetics and Molecular Biology Discontinuation 03 medical and health sciences 0302 clinical medicine Denosumab medicine 030212 general & internal medicine business 610 Medicine & health medicine.drug
DOI:	10.7892/boris.111128
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b6f4365cc5748a3a1ad973e5454c521 Zobrazit plný text záznamu